Besides, transplantation of the carboxy-anhydrase-IX (CAIX)-specific CAR-T cell into 12 patients with CAIX-expressing metastatic renal cell carcinoma (RCC) delivered in-patient proof that intervention could lead to positive anti-tumor responses [97]. This evidence concerns the gene CA9 and neoplasm.